Big strides in solving big human health problems! Careers @ Myeloid
Our Science
// The Impact of Myeloid Cells in Disease
Conductors of the Immune System
Myeloid cells are the front lines of defense against disease, responsible for choreographing downstream immune responses. They’re also versatile, with effector functions capable of killing cancer cells. When applied to a therapeutic candidate, immunotherapy is designed to recognize and engulf cancer cells, produce anti-tumor agents, promote anti-tumor adaptive immunity, alter the tumor microenvironment, and ultimately kill cancer.
// Myeloid Platforms
Multidisciplinary Technologies
Our therapies incorporate advanced cell and gene therapy methods, combining immunology, genetics, cell biology, and protein science to improve the lives of patients in need.
01
Our novel in vivo engineering platform targets and activates myeloid cells within solid tumors to elicit broader anti-tumor adaptive immunity — without the need for ex-vivo cell engineering.
LEARN MORE
01
In Vivo mRNA Programming
02
Our retrotransposon-mediated gene-insertion technology offers the potential to deliver larger genetic sequences into the genome than is currently possible with existing technologies.
LEARN MORE
02
CREATE Gene-Editing
03
Our mRNA technologies utilize myeloid cells to engulf cancer cells, produce anti-tumor agents, promote anti-tumor adaptive immunity, and alter the tumor microenvironment.
LEARN MORE
03
mRNA Cell Therapy
// Our Capabilities
Next-Generation Immunotherapies
Our capabilities translate into unmatched product designs with transformative “full-immune” engagement.